Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595112 | SCV000707675 | pathogenic | not provided | 2017-04-11 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000595112 | SCV002024026 | likely pathogenic | not provided | 2019-05-22 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV001722542 | SCV002512581 | pathogenic | Nephronophthisis 19 | 2021-09-09 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderate, PM3 moderate |
Fulgent Genetics, |
RCV002491217 | SCV002776530 | pathogenic | Autosomal recessive nonsyndromic hearing loss 66; Nephronophthisis 19; Isolated neonatal sclerosing cholangitis | 2021-10-04 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001722542 | SCV001934600 | pathogenic | Nephronophthisis 19 | 2022-04-13 | no assertion criteria provided | literature only |